O. Melander et al., Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension, HYPERTENSIO, 36(3), 2000, pp. 389-394
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Gitelman's syndrome is an autosomal recessive disorder characterized by ele
ctrolyte disturbances and low blood pressure. The disease is caused by homo
zygous or compound heterozygous inactivating mutations in the thiazide-sens
itive NaCl-cotransporter gene leading to reduced renal sodium reabsorption.
We report 4 patients with Gitelman's syndrome from southern Sweden, all in
whom we identified compound heterozygous mutations in the thiazide-sensiti
ve NaCl-cotransporter gene (Gly439Ser, Gly731Arg, Gly741Arg, Thr304Pro, and
2745insAGCA), of which the latter 2 have not been described before. We hyp
othesized that such mutations in their heterozygous form protect against pr
imary hypertension in the general population and that the gene may also har
bor activating mutations that increase the risk for primary hypertension. A
ccordingly, the gene was screened for mutations in 20 patients with primary
hypertension and in 20 normotensive subjects by single-strand conformation
polymorphism and direct DNA sequencing. The Arg904Gln, Gly264Ala, and C142
0T variants, found in the mutation screening of subjects without Gitelman's
syndrome, were studied further. Population genotype frequencies were deter
mined in 292 unrelated patients with primary hypertension and 264 unrelated
normotensive subjects from southern Sweden. Gln904 homozygotes were overre
presented in hypertensive patients compared with normotensive subjects (5 o
f 292 versus 0 of 264; P=0.03). In conclusion, we confirm that Gitelman's s
yndrome is caused by mutations in the thiazide-sensitive NaCl-cotransporter
gene. Our results further suggest that subjects homozygous for the Gln904
variant have an increased risk for development of primary hypertension.